U.S. Pharma Stock News

Kaspi.kz (NasdaqGS:KSPI) is in focus after proposing a quarterly dividend of KZT 850 per ADS and reporting fourth quarter and full year 2025 results that showed higher revenue and resilient annual net income. See our latest analysis for Kaspi.kz. Despite the solid revenue and dividend update, Kaspi.kz’s share price has been under pressure, with a 7 day share price return of a 4.72% decline and a year to date share price return of an 8.28% decline, while the 5 year total shareholder return...

Gambling.com Group (GAMB) closed FY 2025 with Q4 revenue of US$46.2 million and a basic EPS loss of US$0.77, alongside a trailing twelve month basic EPS loss of US$0.93 on revenue of US$165.4 million. The company has seen quarterly revenue move from US$35.3 million and basic EPS of US$0.23 in Q4 2024 to US$46.2 million with a basic EPS loss of US$0.77 in Q4 2025, while trailing twelve month revenue shifted from US$127.2 million with basic EPS of US$0.85 in Q4 2024 to US$165.4 million with a...

Century Therapeutics (IPSC) just posted FY 2025 results that put revenue at US$109.2 million with basic EPS of US$0.51 for the latest half, against a trailing twelve month profile that still shows a loss, with EPS of US$0.11 and net income of US$9.6 million in the red on US$109.2 million of revenue. Over the past year, the company has reported revenue of US$1.6 million and EPS of US$0.82 in early 2024, then US$4.96 million with EPS of US$0.79 in the second half of 2024, and then the latest...

ProFrac Holding (ACDC) closed out FY 2025 with fourth quarter revenue of US$436.5 million and a basic EPS loss of US$0.79, alongside net income excluding extra items of a US$142.6 million loss. Over the past few quarters, the company has seen revenue move from US$600.3 million and a basic EPS loss of US$0.12 in Q1 2025 to US$403.1 million and a basic EPS loss of US$0.60 in Q3 2025. Trailing twelve month figures show revenue at US$1.9 billion and a net loss of US$369 million, setting up a...

Viant Technology (DSP) just closed out FY 2025 with fourth quarter revenue of US$110.1 million and basic EPS of US$0.49, alongside trailing 12 month revenue of US$344.2 million and EPS of US$0.51 that sit against a net profit margin of 2.4%. Over the past few quarters the company has seen revenue move from US$70.6 million in Q1 2025 to US$110.1 million in Q4 2025, with basic EPS ranging from a loss of US$0.07 in Q1 2025 to US$0.49 in Q4 2025. This gives investors a clearer view of how the...

CareCloud (CCLD) has capped FY 2025 with fourth quarter revenue of US$34.4 million and basic EPS of US$0.04, alongside trailing 12 month revenue of US$120.5 million and basic EPS of US$0.10, marking a clean move away from the losses seen earlier in the period. The company has seen quarterly revenue step up from US$27.4 million in Q2 2025 to US$34.4 million in Q4 2025, while quarterly basic EPS has shifted from a loss of US$0.04 in Q1 2025 to positive readings in each subsequent quarter,...

Reliance’s subsidiary AMI Metals recently secured two large U.S. government contracts, supplying steel and logistics for the Department of Homeland Security’s border wall project and aluminum plate processing for Lockheed Martin’s F-35 program. These high-profile infrastructure and defense awards deepen Reliance’s role in specialized metals solutions, potentially broadening its exposure to long-duration, government-backed demand. We’ll now examine how AMI Metals’ new border wall and F-35...

Trinity Capital (NasdaqGS:TRIN) has recently committed growth capital to three MedTech companies: Monteris Medical, Emboline, and Neuros Medical. The financing supports commercialization of Monteris Medical's neurosurgical system, Emboline's heart procedure protection platform, and Neuros Medical's non opioid pain treatment device. These back to back commitments expand Trinity Capital's exposure to advanced medical technologies within its venture lending portfolio. Trinity Capital focuses...

If you are wondering whether Grand Canyon Education's current share price lines up with its underlying value, this breakdown is designed to help you make sense of where it stands today. The stock last closed at US$164.15, with returns of 0.4% decline over 7 days, 3.2% decline over 30 days and 0.7% decline year to date. The 1 year return is a 0.4% decline and the 3 year and 5 year returns are 48.9% and 49.2% respectively. Recent attention on Grand Canyon Education has been shaped by ongoing...

If you are wondering whether American Superconductor's current share price lines up with its underlying worth, this article will walk you through what the numbers actually say. The stock most recently closed at US$29.26, with a 7 day return of a 5.1% decline, a 30 day return of an 8.2% decline, a year to date return of a 7.3% decline, and a 1 year return of 57.0%, along with a very large 3 year return and a 5 year return of 27.8%. These moves sit against a backdrop of ongoing interest in...

Why SFL (NYSE:SFL) Is Catching Investor Attention Now SFL (NYSE:SFL) has been drawing fresh interest after recent trading moves, with the stock showing mixed short term returns but a stronger picture over the past year and beyond. See our latest analysis for SFL. The recent 1 day share price return of 5.68% and 7 day share price return of 7.86% sit against a stronger backdrop, with a 30 day share price return of 9.09% and a 1 year total shareholder return of 35.64%. This suggests momentum has...

If you are wondering whether First Solar's recent share price puts it at a premium or leaves some value on the table, this article walks through what the numbers actually say. The stock last closed at US$197.56, with returns of 3.0% over 7 days, a 12.7% decline over 30 days, a 28.0% decline year to date, and a 48.8% gain over 1 year. These figures can change how investors view both its potential and its risk. Recent news coverage has focused on First Solar's role as a US listed solar module...

In its latest reported quarter, Armstrong World Industries posted 5.6% year-on-year revenue growth and record quarterly and full-year sales and earnings, but both revenue and adjusted operating income came in about 3% below analysts’ estimates. This combination of record performance and shortfalls versus expectations highlights how market sentiment can hinge more on forecasts and relative performance than on headline growth alone. Next, we’ll examine how record results coupled with...

Sprinklr (CXM) has been drawing attention after recent share price moves, with the stock down about 27% over the past 3 months and roughly 36% over the past year. See our latest analysis for Sprinklr. The latest share price of $5.88 leaves Sprinklr with a 90 day share price return of 26.77% decline and a 1 year total shareholder return of 36.09% decline, pointing to fading momentum despite earlier gains. Recent moves appear driven less by short term news and more by investors reassessing...

If you are wondering whether NIO's current share price reflects its true worth, you are not alone. This article focuses on what the numbers say about value rather than the hype. NIO's stock recently closed at US$5.55, with returns of 17.6% over the last 7 days, 11.9% over 30 days, 8.0% year to date. However, longer term returns of 17.3% over 1 year, a 34.7% decline over 3 years, and an 86.7% decline over 5 years give a very different picture of the journey so far. Recent coverage of NIO has...

Voyager Therapeutics, Inc. recently reported fourth-quarter 2025 results showing a net loss of US$27.43 million, improving from US$34.49 million a year earlier, while its full-year 2025 net loss widened to US$119.72 million from US$65.00 million in 2024. Although Voyager reduced its quarterly loss per share, the much larger full-year loss highlights the cost intensity of advancing its neurological disease pipeline. We’ll now examine how Voyager’s improved quarterly loss but much larger...

Zurn Elkay Water Solutions (NYSE:ZWS) reported record annual performance with double digit core sales growth. The company highlighted improved operating margins over the year. Management announced a substantial increase in its dividend. The company also disclosed a significant share repurchase program. Zurn Elkay Water Solutions focuses on water management products and systems, an area that sits at the intersection of infrastructure, building construction, and resource efficiency. With...

Digimarc (DMRC) has just posted its FY 2025 numbers, with Q4 revenue of US$8.9 million, a basic EPS loss of US$0.19, and net income excluding extra items showing a loss of US$4.2 million, setting the tone for how investors will read the full year. Over recent quarters, the company has seen revenue move between US$7.6 million and US$9.4 million while quarterly EPS losses ranged from US$0.19 to US$0.55, giving a clear picture of a business that is still loss making but working through its cost...

If you are wondering whether BioNTech's current share price lines up with its long term potential, starting with a clear look at valuation can help you frame that question more calmly. BioNTech's shares recently closed at US$90.10, with returns of 11.6% decline over the past week, 17.3% decline over the last month, and 6.8% decline year to date, alongside 7.6% decline over 1 year, 31.7% decline over 3 years, and 12.2% decline over 5 years, which hints that the market's view on risk and...

In recent weeks, AMETEK reported quarterly results that exceeded analyst expectations, raised its full-year guidance, and approved a 10% increase in its quarterly cash dividend, while continuing to invest heavily in growth projects. These developments, coupled with long-term institutional backing from investors like GAMCO and increased interest from hedge funds, highlight how AMETEK’s earnings momentum and capital allocation policies are shaping perceptions of its quality and...

Montauk Renewables (MNTK) closed out FY 2025 with Q4 revenue of US$43.4 million and basic EPS of US$0.02 on net income of US$2.5 million, setting the tone for a year where reported earnings and margins were under close watch. The company has seen quarterly revenue move from US$27.7 million and basic EPS of US$0.06 in Q4 2024 to a mix of losses and profits through 2025, including Q2 revenue of US$45.1 million with a loss of US$5.5 million and basic EPS of US$0.04, before landing on US$45.3...

Why DaVita (DVA) is back in the spotlight DaVita (DVA) is back under the microscope after recent analyst reports flagged flat treatment volumes, slower expected sales growth, and pressure on free cash flow margins, even as some ratings remain very positive. See our latest analysis for DaVita. DaVita’s share price has moved to US$153.06, with a 9.9% 1 month share price return and 26.1% 3 month share price return. Its 3 year total shareholder return of 96.2% contrasts with recent concerns over...

Velocity Financial FY 2025 results in focus Velocity Financial (VEL) has wrapped up FY 2025 with fourth quarter total revenue of US$57.1 million and basic EPS of US$0.89, setting the tone for how investors will read the full year. The company has seen quarterly revenue move from US$84.9 million in Q4 2024 to US$57.1 million in Q4 2025, while basic EPS shifted from US$0.62 to US$0.89 over the same period, and on a trailing twelve month basis EPS stands at US$2.81 on revenue of US$183.5...

Oil-Dri Corporation of America (ODC) has just posted Q2 2026 results with revenue of US$117.7 million and basic EPS of US$0.87, alongside trailing twelve month EPS of US$3.62 on revenue of US$478.9 million. Over recent quarters the company has seen revenue move between US$116.9 million and US$127.9 million, while quarterly EPS has ranged from US$0.80 to US$1.13. This sets up a picture of steady top line and earnings performance that now sits on the back of 15.6% earnings growth over the past...